2R9-12553-68290
1 vaccination
0 coded responses
5 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 913 / CA
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-05
Registered in v-safe
-
2021-04-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Itching · Headache, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-06
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-04-07
- 2021-04-08
- 2021-04-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-06 | priority 2/3 |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.